WASHINGTON (June 18, 2018) — Georgetown Lombardi Comprehensive Cancer Center announces the return of physician-scientist Marc E. Lippman, MD, MACP, FRCP, to the cancer center. He begins July 15 as a professor in the departments of oncology and medicine at Georgetown University Medical Center.
From 1988 to 2001, Lippman served as director of Georgetown Lombardi. During his tenure at Georgetown, he also served as chair of the department of oncology, and professor of oncology, medicine and pharmacology at Georgetown University Medical Center. Lippman joins Georgetown Lombardi as a member of the breast cancer program. He will also establish a laboratory and see patients with breast cancer.
“We are both pleased and fortunate to have Marc return to Lombardi,” says Louis M. Weiner, MD, director of Georgetown Lombardi. “He is an exceptional world-class scientist and clinician who brings important depth and breadth to our breast cancer program.”
Most recently, Lippman served as deputy director of Sylvester Comprehensive Cancer Center at the University of Miami, as well as the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Miller School of Medicine.
An accomplished researcher, Lippman is widely known for his work in the investigation and treatment of breast cancer. Before coming to Georgetown Lombardi in 1988, he led the medical breast cancer section of the medicine branch at the National Cancer Institute and was senior investigator from 1974 to 1988. Lippman has been issued multiple patents for his work, including several related to the expression of growth factor receptors in tumor cells.
Lippman holds board certifications in endocrinology and metabolism, and in medical oncology from the Endocrinology, Diabetes, & Metabolism and Medical Oncology specialty boards of the American Board of Internal Medicine.
Throughout his career, Lippman has garnered many honors including a Clinical Investigator Award from the American Federation for Clinical Research, the Transatlantic Medal and Lecture from the British Endocrine Societies, the Astwood Award from the Endocrine Society, the Bernard Fisher Award from the University of Pittsburgh, the Rosenthal Award from the American Association for Cancer Research, and the Brinker Award for Basic Science from the Komen Foundation.
In addition to earning a mastership with the American College of Physicians, Lippman is a member of the Association of American Physicians, the American Society for Clinical Investigation, the American Society of Biological Chemists, the American Association for Cancer Research, and the American Society of Clinical Oncology. Lippman is also a fellow of the Royal College of Physicians.
The author of many chapters and books, including a textbook on breast disease, Lippman has also published over 400 peer-reviewed articles and is editor-in-chief of Breast Cancer Research and Treatment.
Lippman completed his undergraduate education at Cornell University with honors. He attended Yale Medical School, where he was elected to the Alpha Omega Alpha Honor Medical Society. He completed his residency training at John Hopkins Hospital followed by a fellowship in endocrinology at Yale Medical School.
Lippman’s wife, Nanette Bishopric, MD, is a distinguished cardiologist and is also a professor of medicine at the University of Miami Miller School of Medicine, focusing on epigenetic mechanisms underlying heart failure and cancer. She plans to continue working with Lippman on several cancer projects, and will continue her clinical activities at MedStar Washington Hospital Center and MedStar Georgetown University Hospital.
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute as a comprehensive cancer center — the only cancer center of its kind in the Washington, D.C. area. A part of Georgetown University Medical Center and MedStar Georgetown University Hospital, Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Connect with Georgetown Lombardi on Facebook (Facebook.com/GeorgetownLombardi) and Twitter (@LombardiCancer).
About Georgetown University Medical Center
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate) and Twitter (@gumedcenter). Connect with Georgetown University School of Medicine on Facebook (facebook.com/somgeorgetown), Twitter (@gumedicine) and Instagram (@georgetownmedicine).
About Georgetown University
Georgetown University is one of the world’s leading academic and research institutions, offering a unique educational experience that prepares the next generation of global citizens to lead and make a difference in the world. Established in 1789, Georgetown is the nation’s oldest Catholic and Jesuit university. Georgetown today is a major student-centered, international, research university offering respected undergraduate, graduate and professional programs in Washington, D.C.; Doha, Qatar; and around the world. For more information about Georgetown University, visit http://georgetown.edu.